Breaking Down Silos across the Life Sciences Enterprise Helps Drive Innovation
Silos have long plagued the life sciences industry, and nowhere ...
Webinar: Leveraging AI for Intelligent Adverse Event and Product Complaint Intake

Join peers from global pharma to explore how ReporterX is redefining safety and quality complaints intake.
Webinar: The Rise of Intelligence Agents

AI Intelligence agents that interpret regulatory change and assess real-time impact.
Silos have long plagued the life sciences industry, and nowhere ...
CUSTOMER BACKGROUND With a history dating back to the late ...
CUSTOMER BACKGROUND Customer is a leading global pharmaceutical company headquartered ...
Customer Background Incorporated in 1993 as a subsidiary of Biocon ...
The client, a mid-tier biotechnology company with products in a range of therapeutic areas, was struggling with an all-too-familiar challenge: How to effectively collect, organize, triage and archive the large volume of inbound potential AE (Adverse Event) and ADR (Adverse Drug Reaction) reports they received for case processing and reporting.
Global CRO PPD selects ArisGlobal’s cloud-based drug safety database solution to provide its clients with continuous pharmacovigilance regulatory reporting compliance in the most cost-effective way.
Today’s Medical Information (MI) and Medical Affairs professionals are juggling ...
Safety departments at Marketing Authorization Holders & Regulatory Authorities are ...
Rising Expectations from Regulatory Affairs Executives As we all know ...
Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved